Elizabeth Weesner Hosain Ghassemi Iryna Salapenka Jaya Sri Konakanchi Gregory Maggio Roopa Sethi
10.17161/kjm.vol15.17931
Kans J Med
2022 Aug 22;15:302-304.
buprenorphine cellulitis drug side effects opioid use disorder sublocade
CC BY-NC-ND
https://pubmed.ncbi.nlm.nih.gov/36042837/
Case Reports
PMC9409986
36042837
Injection Site Reaction to Extended-Release Buprenorphine (Sublocade®) for Opioid Use Disorder Fourteen Days after Administration
2022